Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figure in Item 6 represents shares of Common Stock, $0.0001 par value per share ("Common Stock") of Gossamer Bio, Inc. (the "Issuer") that may be acquired by the DCIG Capital Master Fund LP, a Cayman Islands limited partnership (the "Fund") within 60 days pursuant to warrants held by the Fund. (2) The figures in Items 8 and 9 represent: (a) 177,975 shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund, and (b) 64,462 shares of Common Stock that may be acquired by a separately managed account within 60 days pursuant to warrants held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 is based upon (i) 242,437 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the U.S. Securities and Exchange Commission (the "SEC") on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 represent Common Stock that may be acquired by the Reporting Persons within 60 days pursuant to warrants held by the Reporting Persons. (2) The figure in Item 11 is based upon (i) 177,975 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 represent Common Stock that may be acquired by the Reporting Persons within 60 days pursuant to warrants held by the Reporting Persons. (2) The figure in Item 11 is based upon (i) 177,975 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figure in Item 6 represents shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund. (2) The figures in Items 8 and 9 represent: (a) 177,975 shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund, and (b) 64,462 shares of Common Stock that may be acquired by a separately managed account within 60 days pursuant to warrants held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 is based upon (i) 242,437 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.


SCHEDULE 13G



 
DeepCurrents Investment Group LLC
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member and President
Date:11/16/2026
 
DCIG GP LLC
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:11/16/2026
 
DCIG Capital Master Fund LP
 
Signature:DCIG GP LLC
Name/Title:General Partner
Date:11/16/2026
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:11/16/2026
 
Kai Zheng
 
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng
Date:11/16/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the SEC on June 11, 2026).